SCOPUS 정보 검색 플랫폼

Volumn 3, Issue 12, 2008, Pages 1863-1868

Bisphosphonated benzoxazinorifamycin prodrugs for the prevention and treatment of osteomyelitis

(15) Reddy, Ranga a Dietrich, Evelyne a Lafontaine, Yanick a Houghton, Tom J a Belanger, Odette a Dubois, Anik a Arhin, Francis F a Sarmiento, Ingrid a Fadhil, Ibtihal a Laquerre, Karine a Ostiguy, Valerie a Lehoux, Dario a Moeck, Gregory a Parr Jr , Thomas R a Rafai Far, Adel a

a Targanta Therapeutics Inc (Canada)

Author keywords

Bisphosphonates; Osteomyelitis; Prodrugs; Rifalazil; Rifamycins

Indexed keywords

ANTIINFECTIVE AGENT; PRODRUG; RIFAMYCIN;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; OSTEOMYELITIS; RAT; STAPHYLOCOCCUS AUREUS; SYNTHESIS;

ANIMALS; ANTI-BACTERIAL AGENTS; OSTEOMYELITIS; PRODRUGS; RATS; RIFAMYCINS; STAPHYLOCOCCUS AUREUS;

EID: 57549101710 PISSN: 18607179 EISSN: 18607187 Source Type: Journal
DOI: 10.1002/cmdc.200800255 Document Type: Article

Times cited : (25)

References (47)

1
- 3242781031
- D. P. Lew, F. A. Waldvogel, Lancet 2004, 364, 369-379.
- (2004) Lancet , vol.364 , pp. 369-379
- Lew, D.P.¹ Waldvogel, F.A.²

2
- 0036556518
- S. Mandal, A. R. Berendt, S. J. Peacock, J. Infect. 2002, 44, 143-151.
- (2002) J. Infect , vol.44 , pp. 143-151
- Mandal, S.¹ Berendt, A.R.² Peacock, S.J.³

3
- 0038434041
- a) A. D. Tice, P. A. Hoaglund, D. A. Shoultz, Am. J. Med. 2003, 114, 723-728;
- (2003) Am. J. Med , vol.114 , pp. 723-728
- Tice, A.D.¹ Hoaglund, P.A.² Shoultz, D.A.³

4
- 0038778626
- b) A. D. Tice, P. A. Hoaglund, D. A. Shoultz, J. Antimicrob. Chemother. 2003, 51, 1261-1268.
- (2003) J. Antimicrob. Chemother , vol.51 , pp. 1261-1268
- Tice, A.D.¹ Hoaglund, P.A.² Shoultz, D.A.³

5
- 21144442488
- P. K. Henke, S. A. Blackburn, R. W. Wainess, J. Cowan, A. Alicia Terando, M. Proctor, T. W. Wakefield, G. R. Upchurch, Jr., J. C. Stanley, L. J. Greenfield, Ann. Surg. 2005, 241, 885-894.
- (2005) Ann. Surg , vol.241 , pp. 885-894
- Henke, P.K.¹ Blackburn, S.A.² Wainess, R.W.³ Cowan, J.⁴ Alicia Terando, A.⁵ Proctor, M.⁶ Wakefield, T.W.⁷ Upchurch Jr., G.R.⁸ Stanley, J.C.⁹ Greenfield, L.J.¹⁰

6
- 0036319253
- For examples of release of antibiotics from impregnated materials, see: a C. L. Nelson, S. G. McLaren, R. A. Skinner, M. S. Smeltzer, J. R. Thomas, K. M. Olsen, J. Orthop. Res. 2002, 20, 643-647;
- For examples of release of antibiotics from impregnated materials, see: a) C. L. Nelson, S. G. McLaren, R. A. Skinner, M. S. Smeltzer, J. R. Thomas, K. M. Olsen, J. Orthop. Res. 2002, 20, 643-647;

7
- 0037202182
- b) M. Baro, E. Sánchez, A. Delgado, A. Perera, C. Évora, J. Controlled Release 2002, 83, 353-364;
- (2002) J. Controlled Release , vol.83 , pp. 353-364
- Baro, M.¹ Sánchez, E.² Delgado, A.³ Perera, A.⁴ Évora, C.⁵

8
- 0344440905
- c) C. Castro, E. Sánchez, A. Delgado, I. Soriano, P. Núñez, M. Baro, A. Perera, C. Évora, J. Controlled Release 2003, 93, 341-354;
- (2003) J. Controlled Release , vol.93 , pp. 341-354
- Castro, C.¹ Sánchez, E.² Delgado, A.³ Soriano, I.⁴ Núñez, P.⁵ Baro, M.⁶ Perera, A.⁷ Évora, C.⁸

9
- 29444453501
- d) T. J. Mäkinen, M. Veiranto, P. Lankinen, N. Moritz, J. Jalava, P. Tö̈rmälä, H. T. Aro, J. Antimicrob. Chemother. 2005, 56, 1063-1068;
- (2005) J. Antimicrob. Chemother , vol.56 , pp. 1063-1068
- Mäkinen, T.J.¹ Veiranto, M.² Lankinen, P.³ Moritz, N.⁴ Jalava, J.⁵ Tö̈rmälä, P.⁶ Aro, H.T.⁷

10
- 85056017635
- e) U. Joostena, A. Joist, G. Goshegerc, U. Liljenqvist, B. Brandt, C. von Eiff, Biomaterials 2005, 26, 5251-5258.
- (2005) Biomaterials , vol.26 , pp. 5251-5258
- Joostena, U.¹ Joist, A.² Goshegerc, G.³ Liljenqvist, U.⁴ Brandt, B.⁵ von Eiff, C.⁶

11
- 0347990350
- a) H. Hirabayashi, J. Fujisaki, Clin. Pharmacokinet. 2003, 42, 1319-1330;
- (2003) Clin. Pharmacokinet , vol.42 , pp. 1319-1330
- Hirabayashi, H.¹ Fujisaki, J.²

12
- 0035992775
- b) H. Uludag, Curr. Pharm. Des. 2002, 8, 1929-1944;
- (2002) Curr. Pharm. Des , vol.8 , pp. 1929-1944
- Uludag, H.¹

13
- 0036259958
- c) J. J. Vepsäläinen, Curr. Med. Chem. 2002, 9, 1201-1208.
- (2002) Curr. Med. Chem , vol.9 , pp. 1201-1208
- Vepsäläinen, J.J.¹

14
- 0035966508
- a) H. Hirabayashi, T. Takahashi, J. Fujisaki, T. Masunaga, S. Sato, J. Hiroi, Y. Tokunaga, S. Kimura, T. Hata, J. Controlled Release 2001, 70, 183-191;
- (2001) J. Controlled Release , vol.70 , pp. 183-191
- Hirabayashi, H.¹ Takahashi, T.² Fujisaki, J.³ Masunaga, T.⁴ Sato, S.⁵ Hiroi, J.⁶ Tokunaga, Y.⁷ Kimura, S.⁸ Hata, T.⁹

15
- 0036875004
- b) H. Hirabayashi, T. Sawamoto, J. Fujisaki, Y. Tokunaga, S. Kimura, T. Hata, Biopharm. Drug Dispos. 2002, 23, 307-315;
- (2002) Biopharm. Drug Dispos , vol.23 , pp. 307-315
- Hirabayashi, H.¹ Sawamoto, T.² Fujisaki, J.³ Tokunaga, Y.⁴ Kimura, S.⁵ Hata, T.⁶

16
- 0033121313
- c) L. Gil, Y. Han, E. E. Opas, G. A. Rodan, R. Ruel, J. G. Seedor, P. C. Tyler, R. N. Young, Bioorg. Med. Chem. 1999, 7, 901-919;
- (1999) Bioorg. Med. Chem , vol.7 , pp. 901-919
- Gil, L.¹ Han, Y.² Opas, E.E.³ Rodan, G.A.⁴ Ruel, R.⁵ Seedor, J.G.⁶ Tyler, P.C.⁷ Young, R.N.⁸

17
- 0035356078
- d) P. C. B. Page, M. J. McKenzie, J. A. Gallagher, J. Org. Chem. 2001, 66, 3704-3708;
- (2001) J. Org. Chem , vol.66 , pp. 3704-3708
- Page, P.C.B.¹ McKenzie, M.J.² Gallagher, J.A.³

18
- 0029590793
- e) J. Fujisaki, Y. Tokunaga, T. Takahashi, T. Hirose, F. Shimojo, A. Kagayama, T. Hata, J. Drug Targeting 1995, 3, 273-282;
- (1995) J. Drug Targeting , vol.3 , pp. 273-282
- Fujisaki, J.¹ Tokunaga, Y.² Takahashi, T.³ Hirose, T.⁴ Shimojo, F.⁵ Kagayama, A.⁶ Hata, T.⁷

19
- 0029800986
- f) J. Fujisaki, Y. Tokunaga, T. Sawamoto, T. Takahashi, S. Kimura, F. Shimojo, T. Hata, J. Drug Targeting 1996, 4, 117-123.
- (1996) J. Drug Targeting , vol.4 , pp. 117-123
- Fujisaki, J.¹ Tokunaga, Y.² Sawamoto, T.³ Takahashi, T.⁴ Kimura, S.⁵ Shimojo, F.⁶ Hata, T.⁷

20
- 0024590567
- a) I. K. Adzamli, H. Gries, D. Johnson, M. Blau, J. Med. Chem. 1989, 32, 139-144;
- (1989) J. Med. Chem , vol.32 , pp. 139-144
- Adzamli, I.K.¹ Gries, H.² Johnson, D.³ Blau, M.⁴

21
- 22644446717
- b) K. Ogawa, T. Mukai, Y. Arano, M. Ono, H. Hanaoka, S. Ishino, K. Hashimoto, H. Nishimura, H. Saji, Bioconjugate Chem. 2005, 16, 751-757;
- (2005) Bioconjugate Chem , vol.16 , pp. 751-757
- Ogawa, K.¹ Mukai, T.² Arano, Y.³ Ono, M.⁴ Hanaoka, H.⁵ Ishino, S.⁶ Hashimoto, K.⁷ Nishimura, H.⁸ Saji, H.⁹

22
- 28444439608
- 16477-16 485
- c) V. Kubíek, J. Rudovsk, J. Kotek, P. Hermann, L. Vander Elst, R. N. Muller, Z. I. Kolar, H. Th. Wolterbeek, J. A. Peters, I. Luke, J. Am. Chem. Soc. 2005, 127, 16477-16 485.
- (2005) J. Am. Chem. Soc , vol.127
- Kubíek, V.¹ Rudovsk, J.² Kotek, J.³ Hermann, P.⁴ Vander Elst, L.⁵ Muller, R.N.⁶ Kolar, Z.I.⁷ Wolterbeek, H.T.⁸ Peters, J.A.⁹ Luke, I.¹⁰

23
- 33746188502
- a) G. Bansal, J. E. I. Wright, C. Kucharski, H. Uludaǧ, Angew. Chem. 2005, 117, 3776-3780;
- (2005) Angew. Chem , vol.117 , pp. 3776-3780
- Bansal, G.¹ Wright, J.E.I.² Kucharski, C.³ Uludaǧ, H.⁴

24
- 20444483335
- Angew. Chem. Int. Ed. 2005, 44, 3710-3714;
- (2005) Angew. Chem. Int. Ed , vol.44 , pp. 3710-3714

25
- 18844415857
- b) D. Wanga, S. C. Miller, P. Kopecćková, J. Kopeček, Adv. Drug Delivery Rev. 2005, 57, 1049-1076;
- (2005) Adv. Drug Delivery Rev , vol.57 , pp. 1049-1076
- Wanga, D.¹ Miller, S.C.² Kopecćková, P.³ Kopeček, J.⁴

26
- 26944464230
- c) J. E. I. Wright, S. A. Gittens, G. Bansal, P. I. Kitov, D. Sindrey, C. Kucharski, H. Uludaǧ, Biomaterials 2006, 27, 769-784.
- (2006) Biomaterials , vol.27 , pp. 769-784
- Wright, J.E.I.¹ Gittens, S.A.² Bansal, G.³ Kitov, P.I.⁴ Sindrey, D.⁵ Kucharski, C.⁶ Uludaǧ, H.⁷

27
- 0037161604
- P. Herczegh, T. B. Buxton, J. C. McPherson III, Á. Kovács-Kulyassa, P. D. Brewer, F. Sztaricskai, G. G. Stroebel, K. M. Plowman, D. Farcasiu, J. F. Hartmann, J. Med. Chem. 2002, 45, 2338-2341;
- (2002) J. Med. Chem , vol.45 , pp. 2338-2341
- Herczegh, P.¹ Buxton, T.B.² McPherson III, J.C.³ Kovács-Kulyassa, A.⁴ Brewer, P.D.⁵ Sztaricskai, F.⁶ Stroebel, G.G.⁷ Plowman, K.M.⁸ Farcasiu, D.⁹ Hartmann, J.F.¹⁰

28
- 0037161604
- Á. Kovács-Kulyassa, P. D. Brewer, F. Sztaricskai, G. G. Stroebel, K. M. Plowman, D. Farcasiu, J. F. Hartmann, J. Med. Chem. 2002, 45, 2338-2341.
- (2002) J. Med. Chem , vol.45 , pp. 2338-2341
- Kovács-Kulyassa, A.¹ Brewer, P.D.² Sztaricskai, F.³ Stroebel, G.G.⁴ Plowman, K.M.⁵ Farcasiu, D.⁶ Hartmann, J.F.⁷

29
- 0034972610
- W. J. Burman, K. Gallicano C. Peloquin, Clin. Pharmacokinet. 2001, 40, 327-341.
- (2001) Clin. Pharmacokinet , vol.40 , pp. 327-341
- Burman, W.J.¹ Gallicano, K.² Peloquin, C.³

30
- 14844356959
- H. G. Floss, T.-W. Yu, Chem. Rev. 2005, 105, 621-632.
- (2005) Chem. Rev , vol.105 , pp. 621-632
- Floss, H.G.¹ Yu, T.-W.²

31
- 0032856709
- a) B. Amorena, E. Gracia, M. Monzón, J. Leiva, C. Oteiza, M. Pérez, J.-L. Alabart, J. Hernández-Yago, J. Antimicrob. Chemother. 1999, 44, 43-55;
- (1999) J. Antimicrob. Chemother , vol.44 , pp. 43-55
- Amorena, B.¹ Gracia, E.² Monzón, M.³ Leiva, J.⁴ Oteiza, C.⁵ Pérez, M.⁶ Alabart, J.-L.⁷ Hernández-Yago, J.⁸

32
- 29944444489
- b) R. Saginur, M. St. Denis, W. Ferris, S. D. Aaron, F. Chan, C. Lee, K. Ramotar, Antimicrob. Agents Chemother. 2006, 50, 55-61;
- (2006) Antimicrob. Agents Chemother , vol.50 , pp. 55-61
- Saginur, R.¹ St. Denis, M.² Ferris, W.³ Aaron, S.D.⁴ Chan, F.⁵ Lee, C.⁶ Ramotar, K.⁷

33
- 35949002764
- c) P. Villain-Guillot, M. Gualtieri, L. Bastide, J. P. Leonetti, Antimicrob. Agents Chemother. 2007, 51, 3117-3121.
- (2007) Antimicrob. Agents Chemother , vol.51 , pp. 3117-3121
- Villain-Guillot, P.¹ Gualtieri, M.² Bastide, L.³ Leonetti, J.P.⁴

34
- 3042623777
- a) E. S. R. Darley, A. P. MacGowan, J. Antimicrob. Chemother. 2004, 53, 928-935;
- (2004) J. Antimicrob. Chemother , vol.53 , pp. 928-935
- Darley, E.S.R.¹ MacGowan, A.P.²

35
- 0031436961
- b) J. P. Rissing, Clin. Infect. Dis. 1997, 25, 1327-1333;
- (1997) Clin. Infect. Dis , vol.25 , pp. 1327-1333
- Rissing, J.P.¹

36
- 57549116518
- Comparative Efficacy of Rifabutin and Gatifloxacin in the Rat Osteomyelitis Model
- poster A-096, Toronto, ON Canada, May
- c) D. Lehoux, F. F. Arhin, I. Fadhil, K. Laquerre, V. Ostiguy, I. Sarmiento, G. Moeck, A. Rafai Far, T. R. Parr Jr., "Comparative Efficacy of Rifabutin and Gatifloxacin in the Rat Osteomyelitis Model", poster A-096, 107th General Meeting of the American Society for Microbiology, Toronto, ON (Canada), May 2007.
- (2007) 107th General Meeting of the American Society for Microbiology
- Lehoux, D.¹ Arhin, F.F.² Fadhil, I.³ Laquerre, K.⁴ Ostiguy, V.⁵ Sarmiento, I.⁶ Moeck, G.⁷ Rafai Far, A.⁸ Parr Jr., T.R.⁹

37
- 0026462673
- T. Yamane, T. Hashizume, K. Yamashita, K. Hosoe, T. Hidaka, K. Watanabe, H. Kawaharada, S. Kudoh, Chem. Pharm. Bull. 1992, 40, 2707-2711.
- (1992) Chem. Pharm. Bull , vol.40 , pp. 2707-2711
- Yamane, T.¹ Hashizume, T.² Yamashita, K.³ Hosoe, K.⁴ Hidaka, T.⁵ Watanabe, K.⁶ Kawaharada, H.⁷ Kudoh, S.⁸

38
- 33745267677
- D. M. Rothstein, C. Shalish, C. K. Murphy, A. Sternlicht, L. A. Campbell, Expert Opin. Invest. Drugs 2006, 15, 603-623.
- (2006) Expert Opin. Invest. Drugs , vol.15 , pp. 603-623
- Rothstein, D.M.¹ Shalish, C.² Murphy, C.K.³ Sternlicht, A.⁴ Campbell, L.A.⁵

39
- 0029666168
- For similar prodrugs, see: a
- For similar prodrugs, see: a) F. Bauss, A. Esswein, K. Reiff, G. Sponer, B. Müller-Beckmann, Calcif. Tissue Int. 1996; 59, 168-173;
- (1996) Calcif. Tissue Int , vol.59 , pp. 168-173
- Bauss, F.¹ Esswein, A.² Reiff, K.³ Sponer, G.⁴ Müller-Beckmann, B.⁵

40
- 0031945527
- b) J. Fujisaki, Y. Tokunaga, T. Takahashi, F. Shimojo, S. Kimura, T. Hata, J. Drug Targeting 1997, 5, 129-138;
- (1997) J. Drug Targeting , vol.5 , pp. 129-138
- Fujisaki, J.¹ Tokunaga, Y.² Takahashi, T.³ Shimojo, F.⁴ Kimura, S.⁵ Hata, T.⁶

41
- 0031393253
- c) J. Fujisaki, Y. Tokunaga, T. Takahashi, S. Kimura, F. Shimojo, T. Hata, Biol. Pharm. Bull. 1997, 20, 1183-1187.
- (1997) Biol. Pharm. Bull , vol.20 , pp. 1183-1187
- Fujisaki, J.¹ Tokunaga, Y.² Takahashi, T.³ Kimura, S.⁴ Shimojo, F.⁵ Hata, T.⁶

42
- 9344270552
- D. Kantoci, J. K. Denike, W. J. Wechter, Synth. Commun. 1996, 26, 2037-2043.
- (1996) Synth. Commun , vol.26 , pp. 2037-2043
- Kantoci, D.¹ Denike, J.K.² Wechter, W.J.³

43
- 56249119442
- S. P. Agarwal, H. Bala, M. M. Ali, Indian J. Pharm. Sci. 1999, 61, 223-226.
- (1999) Indian J. Pharm. Sci , vol.61 , pp. 223-226
- Agarwal, S.P.¹ Bala, H.² Ali, M.M.³

44
- 0021810829
- a) J. T. Mader, Am. J. Med. 1985, 78, 213-217;
- (1985) Am. J. Med , vol.78 , pp. 213-217
- Mader, J.T.¹

45
- 0026460968
- b) T. O'Reilly, S. Kunz, E. Sande, O. Zak, M. A. Sande, M. G. Táuber, Antimicrob. Agents Chemother. 1992, 36, 2693-2697.
- (1992) Antimicrob. Agents Chemother , vol.36 , pp. 2693-2697
- O'Reilly, T.¹ Kunz, S.² Sande, E.³ Zak, O.⁴ Sande, M.A.⁵ Táuber, M.G.⁶

46
- 45549089828
- a) V. Adamo, N. Caristi, M. M. Saccà, G. Ferraro, C. Arcanà, R. Maisano, D. Santini, G. Tonini, Expert Opin. Pharmacother. 2008, 9, 1351-1361;
- (2008) Expert Opin. Pharmacother , vol.9 , pp. 1351-1361
- Adamo, V.¹ Caristi, N.² Saccà, M.M.³ Ferraro, G.⁴ Arcanà, C.⁵ Maisano, R.⁶ Santini, D.⁷ Tonini, G.⁸

47
- 33847413194
- b) C. D. Krueger, P. M. West, M. Sargent, A. E. Lodolce, A. S. Pickard, Ann. Pharmacother. 2007, 41, 276-284.
- (2007) Ann. Pharmacother , vol.41 , pp. 276-284
- Krueger, C.D.¹ West, P.M.² Sargent, M.³ Lodolce, A.E.⁴ Pickard, A.S.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.